Stock Performance Spotlight: Legend Biotech Corp ADR (LEGN) Ends the Day at 49.68, Down by -0.64

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Legend Biotech Corp ADR’s stock clocked out at $49.68, down -0.64% from its previous closing price of $50.00. In other words, the price has decreased by -$0.64 from its previous closing price. On the day, 1.19 million shares were traded. LEGN stock price reached its highest trading level at $50.225 during the session, while it also had its lowest trading level at $48.36.

Ratios:

To gain a deeper understanding of LEGN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.78 and its Current Ratio is at 4.84. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.29.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Redburn Atlantic on October 08, 2024, initiated with a Buy rating and assigned the stock a target price of $86.

On June 17, 2024, Truist started tracking the stock assigning a Buy rating and target price of $88.

H.C. Wainwright reiterated its Buy rating for the stock on May 24, 2024, while the target price for the stock was revised from $86 to $73.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 25 ’24 when Huang Ying bought 1,504 shares for $44.10 per share.

Macomber Lori bought 90,060 shares of LEGN for $4,405,003 on Sep 20 ’24. On Sep 20 ’24, another insider, Yau Wai Man Philip, who serves as the Director of the company, bought 1,946 shares for $51.04 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LEGN now has a Market Capitalization of 9211616256 and an Enterprise Value of 17246928896. For the stock, the TTM Price-to-Sale (P/S) ratio is 19.96 while its Price-to-Book (P/B) ratio in mrq is 7.85. Its current Enterprise Value per Revenue stands at 37.823 whereas that against EBITDA is -47.587.

Stock Price History:

Over the past 52 weeks, LEGN has reached a high of $70.78, while it has fallen to a 52-week low of $38.60. The 50-Day Moving Average of the stock is -5.04%, while the 200-Day Moving Average is calculated to be -6.29%.

Shares Statistics:

It appears that LEGN traded 951.84K shares on average per day over the past three months and 821130 shares per day over the past ten days. A total of 181.91M shares are outstanding, with a floating share count of 181.45M. Insiders hold about 0.94% of the company’s shares, while institutions hold 50.04% stake in the company. Shares short for LEGN as of 1727654400 were 12073737 with a Short Ratio of 12.68, compared to 1724976000 on 10217120. Therefore, it implies a Short% of Shares Outstanding of 12073737 and a Short% of Float of 12.46.

Most Popular